Prostate Cancer
Research

Volume 7 Number 12
December 2019

Home > Disciplines > Publications > Prostate Cancer Research > Volume 7, Year 2019 > Number 12, December

CONTENTS

▼

CASE REPORTS
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
PROGNOSIS
TREATMENT

CASE REPORTS

▲

Pilati E, Nicolotti DG, Ceci F, et al.
68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report.
Clin Nucl Med. 2020 March;45(3):e151–e153. doi:10.1097/RLU.0000000000002884.
Source / Similar articles .

DIAGNOSIS

▲

Eiber M, Krönke M, Wurzer A, Ulbrich L, Jooß L, Maurer T, Horn T, Schiller K, Langbein T, Buschner G, Wester HJ, Weber WA.
18F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy.
J Nucl Med. 2019 Dec 13;jnumed.119.234914. doi: 10.2967/jnumed.119.234914. [Epub ahead of print].
Source / Similar articles .
Related article: Krönke M, et al.,Histologically-confirmed diagnostic efficacy of 18F-rhPSMA-7 positron emission tomography for N-staging of patients with primary high risk prostate cancer. J Nucl Med. 2019 Dec 13;jnumed.119.234906. doi: 10.2967/jnumed.119.234906. [Epub ahead of print]. Source / Similar articles .

Fanti S, Hadaschik B, Herrmann K.
Proposal of Systemic Therapy Response Assessment Criteria in time of PSMA PET/CT imaging: PSMA PET Progression (PPP).
J Nucl Med. 2019 Dec 5;jnumed.119.233817. doi: 10.2967/jnumed.119.233817. [Epub ahead of print].
Source / Similar articles .

Fendler WP, Weber M, Iravani A, Hofman MS, Calais J, Czernin J, Ilhan H, Saad F, Small EJ, Smith MR, Perez PM, Hope TA, Rauscher I, Londhe A, Lopez-Gitlitz A, Cheng S, Maurer T, Herrmann K, Eiber M, Hadaschik B.
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res. 2019 Dec 15;25(24):7448-7454. doi: 10.1158/1078-0432.CCR-19-1050. Epub 2019 Sep 11.
Source / Similar articles .
Related article: Ost P., PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer. Nat Rev Urol. 2019 Dec 20;10.1038/s41585-019-0268-1. Doi: 10.1038/s41585-019-0268-1. [Epub ahead of print]. Source / Similar articles .

Krönke M, Wurzer A, Schwamborn K, Ulbrich L, Jooß L, Maurer T, Horn T, Rauscher I, Haller B, Herz M, Wester HJ, Weber WA, Eiber M.
Histologically-confirmed diagnostic efficacy of 18F-rhPSMA-7 positron emission tomography for N-staging of patients with primary high risk prostate cancer.
J Nucl Med. 2019 Dec 13;jnumed.119.234906. doi: 10.2967/jnumed.119.234906. [Epub ahead of print].
Source / Similar articles .
Related article: Eiber M, et al, 18F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy. J Nucl Med. 2019 Dec 13;jnumed.119.234914. doi: 10.2967/jnumed.119.234914. [Epub ahead of print]. Source / Similar articles .

Michaud L, Touijer K, Mauguen A, et al.
¹¹C-choline PET/CT in recurrent prostate cancer: retrospective analysis in a large US patient series.
J Nucl Med. 2019;jnumed.119.233098. doi:10.2967/jnumed.119.233098. [Epub 2019 Dec 20].
Source / Similar articles .

Hartrampf PE, Seitz AK, Krebs M, Buck AK, Lapa C.
False-negative ¹⁸F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake.
Eur J Nucl Med Mol Imaging. 2019;10.1007/s00259-019-04645-5. doi:10.1007/s00259-019-04645-5.[Epub 2019 Dec 27].
Source / Similar articles .

Huang C, Song G, Wang H, Lin Z, Wang H, Ji G, Zhang S, Guo Y, Li J, Bao Z, Hong P, Du Y, Li P, He Q, He S, Gong Y, Wang X, Zhou L.
Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy.
Prostate Cancer Prostatic Dis. 2019 Aug 5;10.1038/s41391-019-0164-z. doi: 10.1038/s41391-019-0164-z. [Epub ahead of print].
Source / Similar articles .

Ost P.
PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer.
Nat Rev Urol. 2019 Dec 20;10.1038/s41585-019-0268-1. Doi: 10.1038/s41585-019-0268-1. [Epub ahead of print].
Source / Similar articles .
Related article: Fendler WP, et al, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2019 Dec 15;25(24):7448-7454. doi: 10.1158/1078-0432.CCR-19-1050. Epub 2019 Sep 11. Source / Similar articles .

Pak S, Suh YS, Lee DE, et al.
Association Between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer.
J Urol. 2019;101097JU0000000000000704. doi:10.1097/JU.0000000000000704. [Epub 2019 Dec 17]..
Source / Similar articles .

Virseda Rodríguez AJ, Marcos Asensio S, Herrero Polo M, et al.
The impact of time from biopsy to radical prostatectomy on Gleason score undergrading and other related factors.
Actas Urol Esp. 2019;S0210-4806(19)30164-0. doi:10.1016/j.acuro.2019.08.004. [Epub 2019 Dec 13]..
Source / Similar articles .

EPIDEMIOLOGY, RISK FACTORS, PREVENTION

▲

Butler SS, Muralidhar V, Zhao SG, Sanford NN, Franco I, Fullerton ZH, Chavez J, D'Amico AV, Feng FY, Rebbeck TR, Nguyen PL, Mahal BA.
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
Cancer. 2020 Feb 15;126(4):717-724. doi: 10.1002/cncr.32604. Epub 2019 Dec 3.
Source / Similar articles .

PROGNOSIS

▲

Kir G, Arikan EA, Seneldir H, Ankarali H, Oznergiz S, Olgun ZC, Yildirim A.
Determining the cut-off values of tumor diameter, degree of extraprostatic extension, and extent of surgical margin positivity with regard to biochemical recurrence of prostate cancer after radical prostatectomy.
Ann Diagn Pathol. 2019 Nov 22;44:151431. doi: 10.1016/j.anndiagpath.2019.151431. [Epub ahead of print].
Source / Similar articles .

Martini A, Fossati N, Karnes RJ, Boorjian SA, Boeri L, Bossi A, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Robesti D, Bartkowiak D, Böhmer D, Shariat SF, Goldner G, Battaglia A, Joniau S, Berghen C, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A.
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.
Eur Urol Oncol. 2019 Dec 3;S2588-9311(19)30162-2. doi: 10.1016/j.euo.2019.11.003. [Epub ahead of print].
Source / Similar articles .

Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, Kosaka T, Mizuno R, Kikuchi E, Oya M, Jinzaki M.
Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.
Prostate Cancer Prostatic Dis. 2019 Dec;22(4):539-545. Doi: 10.1038/s41391-019-0136-3. Epub 2019 Feb 27.
Source / Similar articles .

Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.
Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.
World J Urol. 2019 Dec 14;10.1007/s00345-019-03053-6. doi: 10.1007/s00345-019-03053-6. [Epub ahead of print].
Source / Similar articles .

Preisser F, Mazzone E, Knipper S, Nazzani S, Bandini M, Shariat SF, Marchioni M, Tian Z, Saad F, Taussky D, Briganti A, Huland H, Graefen M, Tilki D, Karakiewicz PI.
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy.
Can Urol Assoc J. 2019 Nov 29;10.5489/cuaj.6087. doi: 10.5489/cuaj.6087. [Epub ahead of print].
Source / Similar articles .

Waingankar N, Martini A, Griffiths L, Shah P, Paulucci DJ, Kotamarti S, Gul Z, Elmasri M, Yaskiv O, Haines K, Lerner S, Vira M, Kavoussi LR, Tewari AK, Kapoor DA, Olsson CA.
Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
Urol Oncol. 2019 Nov 30;S1078-1439(19)30415-6. doi: 10.1016/j.urolonc.2019.10.009. [Epub ahead of print].
Source / Similar articles .

TREATMENT

▲

Garisto J, Bertolo R, Wilson CA, Kaouk J.
The evolution and resurgence of perineal prostatectomy in the robotic surgical era.
World J Urol. 2019 Dec 6;10.1007/s00345-019-03004-1. doi: 10.1007/s00345-019-03004-1. [Epub ahead of print].
Source / Similar articles .

Malone S, Roy S, Eapen L, E C, MacRae R, Perry G, Bowen J, Samant R, Morgan S, Craig J, Malone K, Grimes S.
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial.
J Clin Oncol. 2019 Dec 12;JCO1901904. Doi: 10.1200/JCO.19.01904. [Epub ahead of print].
Source / Similar articles .

Yokomizo A, Wakabayashi M, Satoh T, et al.
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401).
Eur Urol. 2019;S0302-2838(19)30896-6. doi:10.1016/j.eururo.2019.11.023. [Epub 2019 Dec 19].
Source / Similar articles .

bottom

▲